Study Ties Ovarian Cancer and Hormone Therapy

New York Times

Published: November 12, 2010

More bad news about post-menopausal hormone therapy: a new European study reports that women who take hormones are at significantly increased risk for ovarian cancer, which is rare but often fatal.

Findings from the European Prospective Investigation into Cancer and Nutrition, which included some 126,920 post-menopausal women, were presented at a conference of the American Association for Cancer Research this week in Philadelphia.

After nine years of follow-up, 424 ovarian cancers had been diagnosed. Even after controlling for body mass index, smoking, and several other risk factors, researchers found that women taking post-menopausal hormone therapy had a 29 percent greater risk of ovarian cancer, compared with women who did not use hormones.

Read Full Article…


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.